Saadia Mokhtari

539 total citations
17 papers, 300 citations indexed

About

Saadia Mokhtari is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Saadia Mokhtari has authored 17 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Saadia Mokhtari's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (3 papers). Saadia Mokhtari is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (3 papers). Saadia Mokhtari collaborates with scholars based in France, United States and Saudi Arabia. Saadia Mokhtari's co-authors include Isabelle Ravaux, Andréas Stein, Philippe Brouqui, Hervé Tissot‐Dupont, Christelle Tomei, Line Meddeb, Amélie Menard, Catherine Dhiver, Philippe Colson and Jean‐Christophe Lagier and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Saadia Mokhtari

16 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saadia Mokhtari France 8 205 124 107 68 46 17 300
Gràcia Mateo Spain 10 144 0.7× 144 1.2× 119 1.1× 28 0.4× 45 1.0× 16 300
Luz Alicia González-Hernández Mexico 10 158 0.8× 82 0.7× 98 0.9× 150 2.2× 97 2.1× 35 386
Juan Tiraboschi Spain 13 312 1.5× 108 0.9× 244 2.3× 27 0.4× 81 1.8× 51 382
Elisabet Deig Spain 6 120 0.6× 117 0.9× 126 1.2× 27 0.4× 57 1.2× 12 258
Romina Quercia United Kingdom 10 408 2.0× 114 0.9× 335 3.1× 66 1.0× 75 1.6× 16 491
Sara Serafino Italy 8 132 0.6× 117 0.9× 154 1.4× 178 2.6× 59 1.3× 12 372
Rima Acosta United States 11 474 2.3× 243 2.0× 343 3.2× 35 0.5× 60 1.3× 17 512
Wbeimar Aguilar-Jiménez Colombia 13 162 0.8× 67 0.5× 152 1.4× 51 0.8× 82 1.8× 36 405
Noemi Giustini Italy 10 163 0.8× 163 1.3× 188 1.8× 186 2.7× 72 1.6× 15 449
Chiara Montrucchio Italy 9 126 0.6× 41 0.3× 63 0.6× 23 0.3× 83 1.8× 14 211

Countries citing papers authored by Saadia Mokhtari

Since Specialization
Citations

This map shows the geographic impact of Saadia Mokhtari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saadia Mokhtari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saadia Mokhtari more than expected).

Fields of papers citing papers by Saadia Mokhtari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saadia Mokhtari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saadia Mokhtari. The network helps show where Saadia Mokhtari may publish in the future.

Co-authorship network of co-authors of Saadia Mokhtari

This figure shows the co-authorship network connecting the top 25 collaborators of Saadia Mokhtari. A scholar is included among the top collaborators of Saadia Mokhtari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saadia Mokhtari. Saadia Mokhtari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ravaux, Isabelle, et al.. (2025). Do Malassezia yeasts colonize the guts of people living with HIV?. PLoS ONE. 20(5). e0322982–e0322982.
2.
Lê, Minh, Naïm Bouazza, Florence Gattacceca, et al.. (2020). Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients. British Journal of Clinical Pharmacology. 86(12). 2404–2413. 9 indexed citations
3.
Solas, Caroline, Naïm Bouazza, Minh Lê, et al.. (2019). Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients. Journal of Antimicrobial Chemotherapy. 74(7). 1992–2002. 9 indexed citations
4.
Hamad, Ibrahim, Rita Abou Abdallah, Saadia Mokhtari, et al.. (2018). Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients. PLoS ONE. 13(1). e0191913–e0191913. 24 indexed citations
5.
Mary‐Krause, Murielle, Laurence Bocket, Marguerite Guiguet, et al.. (2018). Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4). Clinical Infectious Diseases. 67(2). 275–282. 10 indexed citations
6.
Gattacceca, Florence, Minh Lê, Yazdan Yazdanpanah, et al.. (2018). Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine. European Journal of Clinical Pharmacology. 74(4). 473–481. 7 indexed citations
8.
Menard, Amélie, Line Meddeb, Hervé Tissot‐Dupont, et al.. (2017). Dolutegravir and weight gain. AIDS. 31(10). 1499–1500. 118 indexed citations
9.
Lagier, Jean‐Christophe, Sophie Hüe, Mathieu Surénaud, et al.. (2016). Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen. BMJ Open Gastroenterology. 3(1). e000080–e000080. 55 indexed citations
10.
Aherfi, Sarah, Anne Motte, Isabelle Ravaux, et al.. (2015). Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France. Journal of Medical Virology. 87(11). 1921–1933. 2 indexed citations
11.
Sanchez, Carole, Nicolas Mounier, Saadia Mokhtari, et al.. (2014). Expression of activating receptors on natural killer cells from AIDS-related lymphoma patients. AIDS Research and Therapy. 11(1). 38–38. 5 indexed citations
12.
Potard, Valérie, David Rey, Isabelle Poizot‐Martin, et al.. (2014). Lopinavir/r no longer recommended as a first‐line regimen: a comparative effectiveness analysis. Journal of the International AIDS Society. 17(1). 19070–19070. 6 indexed citations
13.
14.
Hittinger, Gilles, et al.. (2010). Drug interactions in the elderly HIV‐infected patient. Journal of the International AIDS Society. 13(S4). 1 indexed citations
15.
Solas, Caroline, Marie‐Claude Gagnieu, Isabelle Ravaux, et al.. (2008). Population Pharmacokinetics of Atazanavir in Human Immunodeficiency Virus-Infected Patients. Therapeutic Drug Monitoring. 30(6). 670–673. 29 indexed citations
16.
Potard, Valérie, David Rey, Saadia Mokhtari, et al.. (2007). First-line Highly Active Antiretroviral Regimens in 2001–2002 in the French Hospital Database on HIV: Combination Prescribed and Biological Outcomes. Antiviral Therapy. 12(3). 317–324. 10 indexed citations
17.
Hill, Terry W., et al.. (2002). Proteolytic release of membrane-bound endo-(1,4)-β-glucanase activity associated with cell wall softening inAchlya ambisexualis. Canadian Journal of Microbiology. 48(1). 93–98. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026